loading
Schlusskurs vom Vortag:
$7.77
Offen:
$7.63
24-Stunden-Volumen:
594.27K
Relative Volume:
0.23
Marktkapitalisierung:
$861.15M
Einnahmen:
$24.30M
Nettoeinkommen (Verlust:
$-145.57M
KGV:
-5.8195
EPS:
-1.33
Netto-Cashflow:
$-149.17M
1W Leistung:
-13.84%
1M Leistung:
-9.19%
6M Leistung:
+419.87%
1J Leistung:
+30.84%
1-Tages-Spanne:
Value
$7.58
$7.89
1-Wochen-Bereich:
Value
$6.69
$9.39
52-Wochen-Spanne:
Value
$1.03
$9.70

Tango Therapeutics Inc Stock (TNGX) Company Profile

Name
Firmenname
Tango Therapeutics Inc
Name
Telefon
(857) 320-4900
Name
Adresse
201 BROOKLINE AVENUE, BOSTON
Name
Mitarbeiter
155
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
TNGX's Discussions on Twitter

Vergleichen Sie TNGX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TNGX
Tango Therapeutics Inc
7.74 1.03B 24.30M -145.57M -149.17M -1.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.93 107.73B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.49 62.04B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
482.61 62.73B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
832.77 51.09B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
166.19 34.67B 398.11M -1.03B -868.57M -5.7032

Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-19 Eingeleitet Piper Sandler Overweight
2024-07-17 Eingeleitet Jefferies Buy
2024-04-04 Eingeleitet Cantor Fitzgerald Overweight
2024-02-12 Eingeleitet Piper Sandler Overweight
2023-12-08 Eingeleitet B. Riley Securities Buy
2022-10-20 Hochstufung H.C. Wainwright Neutral → Buy
2021-09-20 Eingeleitet SVB Leerink Outperform
Alle ansehen

Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten

pulisher
07:27 AM

Does Tango Therapeutics Inc. fit your quant trading modelBull Run & Risk Managed Trade Strategies - newser.com

07:27 AM
pulisher
06:14 AM

Ranking Tango Therapeutics Inc. among high performing stocks via tools2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com

06:14 AM
pulisher
02:12 AM

Tango Therapeutics Inc. stock trend outlook and recovery path2025 Price Action Summary & Free Long-Term Investment Growth Plans - newser.com

02:12 AM
pulisher
12:32 PM

Using AI based signals to follow Tango Therapeutics Inc.Market Risk Report & AI Enhanced Execution Alerts - newser.com

12:32 PM
pulisher
Oct 27, 2025

How to build a dashboard for Tango Therapeutics Inc. stockWeekly Risk Summary & AI Enhanced Trading Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Why Tango Therapeutics Inc. stock is trending among retail tradersTrend Reversal & Smart Allocation Stock Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Tango Therapeutics Advances Innovative Cancer Treatment with S095035 Clinical Trial - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Is Tango Therapeutics Inc. stock entering bullish territory2025 Valuation Update & Daily Chart Pattern Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Revolution Medicines and Tango Therapeutics Advance in Targeted Cancer Therapy Study - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Tango Therapeutics’ Promising Update on TNG260 Clinical Study - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Tango Therapeutics (TNGX) Upgraded to Buy: Here's Why - Yahoo Finance

Oct 27, 2025
pulisher
Oct 27, 2025

Tango Therapeutics stock gains as Cantor Fitzgerald reiterates Overweight rating - Investing.com Nigeria

Oct 27, 2025
pulisher
Oct 26, 2025

Multi asset correlation models including Tango Therapeutics Inc.2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com

Oct 26, 2025
pulisher
Oct 24, 2025

Tango Therapeutics Inc. (TNGX) Stock Price | Live Quotes & Charts | NSD - StocksToTrade

Oct 24, 2025
pulisher
Oct 24, 2025

Guggenheim Maintains Tango Therapeutics (TNGX) Buy Recommendation - Nasdaq

Oct 24, 2025

Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$36.41
price down icon 2.28%
$89.53
price down icon 3.80%
$29.12
price up icon 0.31%
$106.58
price up icon 0.39%
biotechnology ONC
$317.50
price up icon 0.41%
$166.19
price up icon 1.40%
Kapitalisierung:     |  Volumen (24h):